Isolation and characterization of rat liver microsomal R-ibuprofenoyl-CoA synthetase

Biochemical Pharmacology

Volumn 52, Issue 7, 1996, Pages 1007-1013

  Brugger, Roland ^a   Alía, Begonia García ^a   Reichel, Christine ^a   Waibel, R ^a   Menzel, Sabine ^a   Brune, Kay ^a   Geisslinger, Gerd ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

2 arylpropion ic acids; ibuprofen; long chain acyl CoA synthetase (EC 6.1.2.3.); palmitoyl CoA; R iboprofenoyl CoA; R S inversion

Indexed keywords

IBUPROFEN; IBUPROFENOYL COENZYME A; IBUPROFENOYL COENZYME A SYNTHETASE; ISOENZYME; LONG CHAIN FATTY ACID COENZYME A LIGASE; PALMITIC ACID; PALMITOYL COENZYME A; TRITON X 100; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CATALYSIS; CHROMATOGRAPHY; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ISOLATION; ENZYME KINETICS; ENZYME PURIFICATION; GEL ELECTROPHORESIS; LIVER MICROSOME METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOSPECIFICITY;

EID: 0030580061     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)00415-7     Document Type: Article

References (36)

1. 1. Hall SD and Xiaotao O, The role of coenzyme A in the biotransformation of 2-arylpropionic acids. Chem Biol Interact 90: 235-251, 1994.
2. 2. Caldwell J, Hutt A and Fournel-Gigleux S, The metabolic chiral inversion and dispositional enantioselectivity of 2-arylpropionic acids and their biological consequences. Biochem Pharmacol 37: 105-114, 1988.
3. 3. Knadler MP and Hall SD, Stereoselective arylpropionyl-CoA thioester formation in vitro. Chirality 2: 67-73, 1990.
4. 4. Tracy TS, Wirthwein DP and Hall SD, Metabolic inversion of (R)-ibuprofen. Formation of ibuprofenyl-coenzyme A. Drug Metab Dispos 21: 114-120, 1993.
5. 5. Menzel S, Waibel R, Brune K and Geisslinger G, Is the formation of R-ibuprofenyl-adenylate the first stereoselective step of chiral inversion? Biochem Pharmacol 48: 1056-1058, 1994.
6. 6. Tracy TS and Hall SD, Metabolic inversion of (R)-ibuprofen: epimerization and hydrolysis of ibuprofenyl-coenzyme A. Drug Metab Dispos 20: 322-327, 1992.
7. 7. Chen CS, Shieh WR, Lu PH, Harriman S and Chen SY, Metabolic stereoisomeric inversion of ibuprofen in mammals. Biochim Biophys Acta 1078: 411-417, 1991.
8. 8. Shieh WR and Chen CS, Purification and characterization of novel "2-arylpropionyl-CoA epimerases" from rat liver cytosol and mitochondria. J Biol Chem 268: 3487-3493, 1993.
9. 9. Reichel C, Bang H, Brune K, Geisslinger G and Menzel S, 2-arylpropionyl-CoA epimerase: Partial peptide sequences and tissue localization. Biochem Pharmacol 50: 1803-1806, 1995.
10. 10. Knihinicki RD, Day RO and Williams KM, Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs II. Racemization and hydrolysis of (R)-and (S)-ibuprofen-CoA thioesters. Biochem Pharmacol 42: 1905-1911, 1991.
11. 11. Menzel-Soglowek S, Geisslinger G, Mollenhauer J, and Brune K, Metabolic chiral inversion of 2-arylpropionates in rat H4IIE and human HEP G2 hepatoma cells. Biochem Pharmacol 43: 1487-1492, 1992.
12. 12. Sanins SM, Adams WJ, Kaiser DG, Halstead GW and Baillie TA, Studies on the metabolism and chiral inversion of ibuprofen in isolated rat hepatocytes. Drug Metab Dispos 18: 527-532, 1990.
13. 13. Cox JW, Cox SR, VanGiessen and Ruwart MJ, Ibuprofen stereoisomer hepatic clearance and distribution in normal and fatty in situ perfused rat liver. J Pharmacol Exp Ther 232: 636-641, 1985.
14. 14. Hall SD, Hassanzadeh-Khayyat M, Knadler MP and Mayer PR, Pulmonary inversion of 2-arylpropionic acids: Influence of protein binding. Chirality 4: 349-352, 1992.
15. 15. Nakamura Y and Yamaguchi T, Stereoselective metabolism of 2-phenylpropionic acid in rat. 1. In vitro studies on the stereoselective isomerization and glucuronidation of 2-phenylpropionic acid. Drug Metab Disopos 15: 529-534, 1987.
16. 16. Berry BW and Jamali F, Presystemic and systemic chiral inversion of R-ibuprofen in the rat. J Pharmacol Exp Ther 258: 695-702, 1991.
17. 17. Suzuki H, Kawarabayasi Y, Kondo J, Abe T, Nishikawa K, Kimura S, Hashimoto T and Yamamoto T, Structure and regulation of rat long-chain acyl-CoA synthetase. J Biol Chem 265: 8681-8685, 1990.
18. 18. Wechter WJ, Loughhead DG, Reischer RJ, VanGiessen GJ and Kaiser DG, Enzymatic inversion at saturated carbon: Nature and mechanism of the inversion of R(-)p-iso-butyl hydratropic acid, Biochem Biophys Res Commun 61: 833-841, 1974.
19. 19. Bronfman M, Amigo L and Morales MN, Activation of hypolipidaemic drugs to acyl-coenzyme A thioesters. Biochem J 239: 781-784, 1986.
20. 20. Bronfman M, Morales MN, Amigo L, Orellana A, Munez L, Cardenas L and Hidalgo PC, Hypolipidaemic drugs are activated to acyl-CoA esters in isolated rat hepatocytes. Detection of drug activation in human liver homogenates and human platelets. Biochem J 284: 289-295, 1992.
21. 21. Benoit E, Delatour P, Olivier L and Caldwell J, (-)-R-fenoprofen: formation of fenoprofenyl-coenzyme A by rat liver microsomes. Biochem Pharmacol 49: 1717-1720, 1995.
22. 22. Roberts BJ, MacLeod JK, Singh I and Knights KM, Kinetic characteristics of rat liver peroxisomal nafenopin-CoA ligase. Biochem Pharmacol 49: 1335-1339, 1995.
23. 23. Tanaka Y, Shimomura Y, Hirota T, Nozaki A, Ebata M, Takasaki W, Shigehara E, Hayashi R and Caldwell J, Formation of glycine conjugate and (-)-(R)-enantiomer from (+)-(S)-2-phenylpropionic acid suggesting the formation of the CoA thioester intermediate of (+)-(S)-enantiomer in dogs. Chirality 4: 342-348, 1992.
24. 24. Sallustio BC, Meffin PJ and Knights K, The stereospecific incorporation of fenoprofen into rat hepatocyte and adipocyte triacylglycerols. Biochem Pharmacol 42: 1905-1911, 1991.
25. 25. Tanaka T, Hosaka K, Hoshimar M, and Numa S, Purification and properties of long-chain acyl-coenzyme-A synthetase from rat liver. Eur J Biochem 98: 165-172, 1979.
26. 26. Porubek DJ, Sanins SM, Stephens JR, Grillo MP, Kaiser DG, Halstead GW, Adams WJ and Baillie TA, Metabolic chiral inversion of flurbiprofen-CoA in vitro. Biochem Pharmacol 42: R1-R4, 1991.
27. 27. Scheuerer S, Williams KM, Sauernheimer C, McLachlan AJ, Brune K, Day RO and Geisslinger G, Effect of clofibrate on the chiral inversion of ibuprofen in rats. J Pharmacol Exp Ther (submitted).
28. 28. Laemmli UK, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
29. M in enzyme reactions. Science 116: 329-331, 1952.
30. 30. Dixon M, The determination of enzyme inhibitor constants. Biochem J 55: 170-171, 1953.
31. 31. Das DK, Acyl CoA synthetase from rat lung purification and properties. Lung 160: 207-218, 1982.
32. 32. Philipp DP and Parsons P, Kinetic characterization of long chain fatty acyl coenzyme A ligase from rat liver mitochondria. J Biol Chem 254: 10785-10790, 1979.
33. 33. Fujino T and Yamamoto T, Cloning and functional expression of a novel long-chain acyl-CoA synthetase expressed in brain. J Biochem 111: 197-203, 1992.
34. 34. Knights KM and Jones ME, Inhibition kinetics of hepatic microsomal long chain fatty acid-CoA ligase by 20-arylpropionic acid non-steroidal anti-inflammatory drugs. Biochem Pharmacol 43: 1465-1471, 1992.
35. 35. Roberts BJ and Knights KM, Inhibition of rat peroxisomal palmitoyl-CoA ligase by xenobiotic carboxylic acids. Biochem Pharmacol 44: 261-267, 1992.
36. 36. Knights KM, Talbot UM and Baillie TA, Evidence for multiple forms of rat liver microsomal coenzyme A ligase catalysing the formation of 2-arylpropionyl-coenzyme A thioesters. Biochem Pharmacol 44: 2415-2417, 1992.